not tagged
not tagged
['solid tumor']
#asco22 | poster 189a | mon 1:15pm cdt
design and rationale of a first-in-human phase 1/1b study evaluating kin-3248, a next-generation, irreversible, pan-fgfr inhibitor, in adult patients with solid tumors harboring fgfr2....
presenter: lipika goyal, md 
The official Twitter account for Mass General Cancer Center, a member of Mass General Brigham.